Skip to main content

COVID-19 Topic Center

Cardiovascular Expert Insights

Pharmacy Learning Network
Atrial fibrillation is a major health care disorder being the most common arrhythmia, is associated with low quality of life, increased risk of morbidity and mortality, and a very high cost burden.1 Advancing age and tobacco smoking, alcohol abuse, obesity, diabetes, myocardial infarction and heart…
Pharmacy Learning Network
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume 2, Issue 4 Recent data shows that despite all efforts from the heart failure community and in spite of contemporary guideline-directed medical therapy, deaths from heart failure (HF) continue to rise. The rates of death remain…
Pharmacy Learning Network
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume 2, Issue 3 Despite optimal medical therapy—which commonly consists of a cocktail of cardioprotective agents such as antiplatelet, statin, and antihypertensive medications—a significant number of patients with coronary artery…
Pharmacy Learning Network
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS Volume 2, Issue 2 “…pressure…pushing down on me, pressing down on you…” Under Pressure is certainly as true today as ever, as hypertension continues to inflict a ghastly toll on the adult American population. Using the most recent…
Pharmacy Learning Network
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS Volume 2, Issue 1 “Searching for INSPIRATION in all the wrong places.” When trying to talk your way out of a “sticky” situation, nothing helps more than being equipped with the latest and greatest evidence. Unfortunately, when it…
Pharmacy Learning Network
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume 1, Issue 4 The saga of fish oils products, which are commonly comprised of various omega-3 fatty acid preparations, is a long and serpentine one which is both perpetually bolstered by optimism while simultaneously marred by…
Pharmacy Learning Network
Psychiatric disease affects approximately 51 million U.S. citizens (20.6% of U.S. Adults) per year.1 Schizophrenia is a chronic severe neurological brain disorder estimated to affect 1.1 percent of the population or approximately 2.6 million adults in the United States aged 18 or older. An…
Pharmacy Learning Network
By Yvette C Terrie, BS Pharm, RPh, consultant pharmacist Cardiovascular disease (CVD) continues to be the leading cause of death among both men and women in the United States, and globally with CVD contributing to 1 in 3 deaths in women annually.1 According to the CDC, while some progress has been…
Pharmacy Learning Network
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS Volume 1, Issue 2 “A rose by any other name would smell as sweet” When it comes to managing patients with heart failure (HF), it’s all in the name. For patients classified as heart failure with reduced ejection fraction (HFrEF), there…
Pharmacy Learning Network
Cardiovascular health across the world is declining, especially in the older population.1-2 The rate of decline began in 2011 with downward trends in heart disease deaths and stroke in middle-aged Americans.  From 2011-2017 the rate of decline in cardiovascular mortality was 4%.3-5   Unfortunately…
Back to Top